sublingual, IM, IV, transdermal, intranasal, rectallyon
排泄
biliary and renal
蛋白结合率
96%
Schedule III (V some states) (USA) Schedule 8 (Aust) Class C(UK) Cat. A Singapore Schedule III Germany
C (USA)
55%(sublingual)/48.2% +/- 8.35%(intranasal)
法定药品分级
妊娠期药物分类
生物利用度
CAS 52485-79-7|buprenorphine|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1<sup>2</sup>,<sup>8</sup>.0<sup>1</sup>,... | Molfinder